Home / Doxercalciferol / United States
US ATC H05BX03 · updated 2 Nov 2026
Doxercalciferol shortage in United States
Is there a Doxercalciferol shortage in United States?
Yes. As of 2 Nov 2026, 3 Doxercalciferol products are reported short in United States, the first since 10 Dec 2025. No return date has been given. Main reason: not stated.
Not reported short in any other country we track. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Hectorol, Injection, 2 mcg/mL injection 50 single-dose vials (NDC 58468-0126-1) discontinuation | Sanofi-Aventis U.S. LLC | 10 Dec 2025 | not given | Not stated |
| US | Hectorol, Injection, 4 mcg/2 mL injection 50 multiple-dose vials (NDC 58468-0127-1) discontinuation | Sanofi-Aventis U.S. LLC | 10 Dec 2025 | not given | Not stated |
| US | Hectorol, Injection, 4 mcg/2 mL injection 50 single-dose vials (NDC 58468-0123-1) discontinuation | Sanofi-Aventis U.S. LLC | 10 Dec 2025 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).